MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI (Pediatric Brain Tumor Protocol)

Trial Profile

MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI (Pediatric Brain Tumor Protocol)

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 20 Jul 2017

At a glance

  • Drugs Ferumoxytol (Primary)
  • Indications Brain cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 20 Jul 2017 Last checked against ClinicalTrials.gov record.
    • 06 Jul 2017 Planned End Date changed from 1 Jun 2019 to 1 Jul 2019.
    • 06 Jul 2017 Planned primary completion date changed from 1 Jun 2019 to 1 Jul 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top